Kristjansen P E, Roberge S, Lee I, Jain R K
Steele Laboratory, Department of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital-Cox 7, Boston 02114.
Microvasc Res. 1994 Nov;48(3):389-402. doi: 10.1006/mvre.1994.1063.
An ex vivo perfused solid tumor preparation provides control over the physiological, biochemical, and pharmacological composition of the arterial input and easy access to the venous output. This is advantageous for studies of transport and metabolism in solid tumors. Here we present a tissue-isolated tumor preparation adapted to the nude mouse, allowing ex vivo perfusion of human tumor xenografts. Previously, such preparations have only been developed in rats, to study primarily rodent tumors. In the present study this new tumor preparation is physiologically characterized in comparison with subcutaneously transplanted tumors in nude mice using the human colon adenocarcinoma LS174T.
一种离体灌注实体瘤制剂可控制动脉输入的生理、生化和药理成分,并便于获取静脉输出。这对于实体瘤的转运和代谢研究具有优势。在此,我们展示了一种适用于裸鼠的组织分离肿瘤制剂,可对人肿瘤异种移植进行离体灌注。此前,此类制剂仅在大鼠中开发,主要用于研究啮齿类动物肿瘤。在本研究中,使用人结肠腺癌LS174T,将这种新的肿瘤制剂与裸鼠皮下移植肿瘤进行了生理学特征比较。